Company news

Swedish Orphan Biovitrum AB news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Sobi announces revised full year outlook and advances publication of the Q3 2025 financial report

October 19, 2025

Invitation: Sobi's Q3 2025 report

October 8, 2025

Sobi Selects Kinaxis to Accelerate Access to Life-Changing Treatments

October 2, 2025

New number of shares and votes in Sobi

September 30, 2025

Tryngolza ® (olezarsen) approved in the European Union for familial chylomicronemia syndrome (FCS)

September 19, 2025

Invitation: Sobi's NASP and Uncontrolled Gout call and webcast

September 10, 2025

FDA Accepts Biologics License Application for Sobi's NASP for Patients with Uncontrolled Gout

September 10, 2025

Sobi has completed issues of class C shares

August 21, 2025

TRYNGOLZA® (olezarsen) recommended for EU approval by CHMP for familial chylomicronemia syndrome (FCS)

July 25, 2025

Sobi publishes Q2 2025 report: Continued strong portfolio and pipeline momentum

July 16, 2025

The Board of Directors of Sobi exercises authorisation for repurchase of shares for the purpose of securing the company's commitments under incentive programmes

July 15, 2025

Invitation: Sobi's Q2 report

July 2, 2025

Sobi to amend existing agreement with Apellis for ex-U.S. royalties of Aspaveli® (systemic pegcetacoplan)

July 1, 2025

FDA approves Gamifant® (emapalumab-lzsg) as first-ever treatment for adults and children with Macrophage Activation Syndrome in Still's disease

June 27, 2025

Sobi will showcase extensive research and clinical outcomes at ISTH 2025

June 20, 2025

Sobi share new clinical data across multiple hematologic diseases at EHA 2025

June 12, 2025

Sobi and Apellis: Aspaveli®/Empaveli® Demonstrates Sustained One-Year Efficacy in Phase 3 Study for Rare Kidney Diseases

June 6, 2025

Sobi Showcases Breadth of data in C3G/primary IC-MPGN at ERA 2025

June 4, 2025

Invitation: Sobi's Aspaveli® - 52-week Phase 3 VALIANT data in nephrology

June 3, 2025

Sobi to share new clinical data and research at EULAR 2025

May 28, 2025

Sobi publishes Q1 2025 report: Portfolio continues to deliver

April 29, 2025

Sobi presents clinical data at WFH 2025 Comprehensive Care Summit

April 23, 2025

← Newer news releases

Calls

The 5 newest of 15 calls. Every call is listed under its year.

Decks

The 5 newest of 87 decks. Every deck is listed under its year.